Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Stem cell mobilization

Cashen AF, Nervi B, DiPersio J (2007) AMD3100 CXCR4 antagonist and rapid stem cell-mobilizing agent. Future Oncol 3 19-27... [Pg.214]

Nervi B, Link DC, DiPersio JF (2006) Cytokines and hematopoietic stem cell mobilization. J Cell Biochem 99 690-705... [Pg.269]

Levesque JP, Hendy J, Takamatsu Y, Simmons PJ, Bendall LJ. Disruption of the CXCR4/CXCL12 chemotactic interaction during hematopoietic stem cell mobilization induced by GCSF or cyclophosphamide. J Clin Invest 2003 111(2) 187-196. [Pg.134]

Pelus LM, Horowitz D, Cooper SC, King AG. Peripheral blood stem cell mobilization. A role for CXC chemokines. Crit Rev Oncol Hematol 2002 43(3) 257-275. [Pg.134]

Pruijt JF, Verzaal P, van Os R, et al. Neutrophils are indispensable for hematopoietic stem cell mobilization induced by interleukin-8 in mice. Proc Nad Acad Sci USA 2002 99(9) 6228-6233. [Pg.135]

Fapidot T, Petit I. Current understanding of stem cell mobilization the roles of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and stromal cells. Exp Hematol 2002 30(9) 973-981. [Pg.135]

Stem cell mobilization Anti-cancer HIV infection... [Pg.148]

Stem cell mobilization, DC expansion CIAS1 associated periodic syndromes Dendritic cells Peripheral neuropathy MTD... [Pg.148]

Stem cell therapy involves infusion of specialized cells utilized to perform specific functions. The traditional use of cell therapy includes harvest and cryopreservation of autologous hematopoietic cells either from the bone marrow (old approach) or mobilization and pheresis of hematopoietic stem cells from peripheral blood using stem cell-mobilizing cytokines such as hematopoietic colony-stimulating factors (G-CSF, GM-CSF) or chemokine inhibitors (AMD-3100). A more recent stem cell source is umbilical cord blood that has rich pleuripotent potential and can engraft at lower doses than bone marrow or mobilized peripheral blood stem cells. [Pg.212]

Seller C, Montuori N, Ricci P et al. Involvement of the urokinase-type plasminogen activator receptor in hematopoietic stem cell mobilization. Blood. 2005 105 2198-2205. [Pg.61]

Pelus LM Peripheral blood stem cell mobilization New regimens, new cells, where do we stand. Curr Opin Hematol 2008 15 285. [PMID 18536564]... [Pg.752]

Valgimigli M, Rigolin GM, Cittani C, Malagutti P, et al. 2005. Use of granulocyte-colony stimulating factor during acute myocardial infarction to enhance bone marrow stem cell mobilization in humans. Eur Heart J. 26 1838-1845. [Pg.58]

Zohlnhofer D, Ott I, Mehilli J, Schoming K, et al. 2006. Stem cell mobilization by granulocyte-colony-stimulating factor in patients with acute myocardial infarction. JAMA. 295 1003-1010. [Pg.60]

De Clercq E (2009) The AMD3100 story the path to the discovery of a stem cell mobilize (Mozobil). Biochem Pharmacol 77 1655-1664... [Pg.229]

Fatal non-cardiac pulmonary edema has been reported in a 59-year-old man with renal amyloidosis who received G-CSF for 3 days for stem cell mobilization (34). [Pg.1544]

Erythema exsudativum multiforme developed in a 40-year-old healthy donor 3 days after lenograstim was started for peripheral blood stem cell mobilization (58). The lesions were on the hips, apart from the site of lenograstim injection, and resolved 1 week after withdrawal. [Pg.1546]

Murata M, Harada M, Kato S, Takahashi S, Ogawa H, Okamoto S, Tsuchiya S, Sakamaki H, Akiyama Y, Kodera Y. Peripheral blood stem cell mobilization and apheresis analysis of adverse events in 94 normal donors. Bone Marrow Transplant 1999 24(10) 1065-71. [Pg.1550]

GF is a 43-year-old man with Burkitt s lymphoma who is about to receive high-dose cyclophosphamide (4000 mg/m for one dose) for stem cell mobilization. Which of the following factors should be considered prior to administration ... [Pg.144]

Kessinger A, Sharp JG. The whys and hows of hematopoietic progenitor and stem cell mobilization. Bone Marrow Transplant 2003 31 319-329. [Pg.2555]

Fruehauf S, Seggewiss R. It s moving day factors affecting peripheral blood stem cell mobilization and strategies for improvement. Br J Haematol 2003 122 360-375. [Pg.2555]

Petit I, Szyper-Kravitz M., Nagler A., Lahav M., et al. (2002) G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nat Immunol., 3, 687-94. [Pg.39]

See other pages where Stem cell mobilization is mentioned: [Pg.9]    [Pg.135]    [Pg.515]    [Pg.516]    [Pg.595]    [Pg.621]    [Pg.108]    [Pg.314]    [Pg.106]    [Pg.127]    [Pg.139]    [Pg.447]    [Pg.1543]    [Pg.64]    [Pg.2320]    [Pg.2321]    [Pg.458]    [Pg.26]    [Pg.39]    [Pg.455]    [Pg.169]    [Pg.457]    [Pg.508]   
See also in sourсe #XX -- [ Pg.106 ]



SEARCH



Mobile - Human Embryonic Stem Cells and Other Sources for Cell Therapy

Mobile cells

Mobility cell

© 2024 chempedia.info